 |
DAEJEON, South Korea, Nov. 16, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks) announced today that the company will present the final results of the Phase IIa clinical trial of Olinvacimab for rGBM (recurrent glioblastoma multiforme) patients at SNO (Society of Neuro-Oncology) 2020.
The clinical study was conducted in Australiafr...
By Lauren Anderson, Workplace Expert at Indeed Job scams are no longer the obvious, poorly written emails many Australians...
As Queensland prepares for Small Business Month in May, Experience Eumundi is highlighting the critical role the iconic Eum...
Board seats carry prestige, influence and, in some cases, substantial remuneration. But the reality is less glamorous tha...
The question of what comes next for Apple Inc. is no longer theoretical. With leadership transitio...
A 20-year-old man has been fined close to $50,000 and ordered to pay costs after pleading guilty t...
The question of what comes next for Apple Inc. is no longer theoretical. With leadership transitio...
Club Med, the global leader in premium all-inclusive holidays for 75 years, and Central Group Capita...
In an age dominated by screens, taps and instant communication, the simple act of writing by hand ...
Owning a restaurant has long been one of the most alluring—and misunderstood—paths in small busine...
For many Australians, the weekly grocery shop and a simple night out for dinner have quietly becom...
When The Devil Wears Prada premiered in 2006, it was marketed as a sharp, entertaining adaptation ...
Selling a premium home is rarely just about listing and waiting. At the top end of the market, buy...
As Queensland prepares for Small Business Month in May, Experience Eumundi is highlighting the cri...
Club Med, the global leader in premium all-inclusive holidays for 75 years, and Central Group Capita...
COST OF LIVING ‘CRUNCH’ HITS FARRER HARD, THE NATIONALS HEAR During a visit to Albury this week...
HIT LIVE SHOW TWO PSYCHICS AND A MEDIUM EMBARK ON AUSTRALIAN TOUR — AND NO TWO NIGHTS WILL BE T...